← Back to all trials
Recruiting
NCT07902388
Methylation Analyses for Gynaecological Research Through Home-based Self-sampling
Conditions: Healthy Adult Participants, Gynecological Disease
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 512
Sponsor: Universiteit Antwerpen
Location: University of Antwerp, Center for the Evaluation of Vaccination, Vaccinopolis Edegem Antwerp
Summary
The goal of the MARGOT study is to collect self-samples, such as first-void urine and vaginal samples, from people without cancer and compare them with samples from people with gynecological (pre-)cancers collected in other studies, to better understand the differences in biological markers present in these samples between these two groups.
Eligibility Criteria
Inclusion Criteria:
* Individuals having female genital organs, regardless of their gender identity
* Participant is 18 years or older at the time of signing the informed consent form
* Participant must be able to understand the (Dutch) information consent form and what the study is about
* Participant must be able to provide written informed consent and take urine- and vaginal self-samples
* Individual has a Belgian nationality
Exclusion Criteria:
* Individuals that underwent hysterectomy or ovariectomy
* Pregnant individuals or 6 months post-partum
* (History of) (pre)cancer, or an ongoing diagnostic work-up or treatment for oncological concerns
* Unable to give informed consent or to take urine- or vaginal self-samples
* Participation in another interventional study. However, participation in another low-interventional or observational study is allowed
* Individuals who have (a history) of postmenopausal bleeding
Source: ClinicalTrials.gov (NCT07902388). StuddyBuddy aggregates publicly available trial information.